Effect of pentaglobin and piperacillin on survival in a rat model of faecal peritonitis: importance of intervention timings

被引:15
作者
Jacobs, S
Sobki, S
Morais, C
Tariq, M
机构
[1] Armed Forces Hosp, Dept Anesthesia, Riyadh 11159, Saudi Arabia
[2] Armed Forces Hosp, Res Ctr, Riyadh 11159, Saudi Arabia
关键词
fecal peritonitis; sepsis; pentaglobin; piperacillin; free radicals;
D O I
10.1034/j.1399-6576.2000.440116.x
中图分类号
R614 [麻醉学];
学科分类号
100217 [麻醉学];
摘要
Background: Faecal peritonitis is a progressive pathophysiological condition which may lead to multiple organ failure and death The reason for the associated morbidity and mortality could be attributed to the fact that some of the subtle alterations in cellular function that occur during the early stage of peritonitis are unidentified and consequently missed, leading to inadequate or delayed intervention. Recent studies have shown that early treatment with antibiotic and antisera containing antibodies to lipopolysaccharide (immunoglobulin) improve the survival rate in these patients. The present investigation was undertaken to study the effect of pentaglobin and piperacillin with particular attention to time lag of drug intervention on animal survival following experimental peritonitis. Methods: Experimental peritonitis was produced by inoculating 1 ml/kg of faecal suspension (2:1 w/v in saline) into the peritoneal cavity. Two groups of animals were treated with pentaglobin (4 ml/kg) or piperacillin (1000 mg/kg) respectively whereas rats in another group received both drugs simultaneously. The first dose of each drug was given at 4 h, 6 h, 8 h and 12 h after faecal inoculation followed by 3 additional doses at 8-h intervals. For biochemical studies, separate groups of animals were used in which the treatment was started 4 h after faecal inoculation and the animals were killed at 12 h after the treatment. Results: Both piperacillin and pentaglobin prolonged survival time of animals which received the treatment within 6 h of faecal insult. The combination of pentaglobin plus piperacillin produced better results as compared to the individual effect. There was a significant decrease in serum superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) and increase in catalase following faeces-induced septicaemia, suggesting a significant increase in oxidative stress. The changes in enzyme levels were significantly attenuated by both the drugs. Conclusion: The findings suggest that intervention with a combination of pentaglobin and antibiotics within 6 h of peritonitis might significantly improve survival rate in rat.
引用
收藏
页码:88 / 95
页数:8
相关论文
共 44 条
[1]
ALMDAHL SM, 1985, ACTA CHIR SCAND, V151, P213
[2]
An open, multicenter clinical trial of piperacillin tazobactam in the treatment of pediatric patients with intra-abdominal infections [J].
Arguedas, A ;
SifuentesOsornio, J ;
Loaiza, C ;
Herrera, M ;
Corrales, JC ;
Mohs, E .
JOURNAL OF CHEMOTHERAPY, 1996, 8 (02) :130-136
[3]
TISSUE FRACTIONATION STUDIES .17. INTRACELLULAR DISTRIBUTION OF MONOAMINE OXIDASE ASPARTATE AMINOTRANSFERASE ALANINE AMINOTRANSFERASE D-AMINO ACID OXIDASE + CATALASE IN RAT-LIVER TISSUE [J].
BAUDHUIN, P ;
BEAUFAY, H ;
SELLINGER, OZ ;
RAHMANLI, Y ;
DEDUVE, C ;
WATTIAUX, R ;
JACQUES, P .
BIOCHEMICAL JOURNAL, 1964, 92 (01) :179-+
[4]
ENDOTOXIN CONCENTRATION IN NEUTROPENIC PATIENTS WITH SUSPECTED GRAM-NEGATIVE SEPSIS - CORRELATION WITH CLINICAL OUTCOME AND DETERMINATION OF ANTIENDOTOXIN CORE ANTIBODIES DURING THERAPY WITH POLYCLONAL IMMUNOGLOBULIN-M-ENRICHED IMMUNOGLOBULINS [J].
BEHRE, G ;
SCHEDEL, I ;
NENTWIG, B ;
WORMANN, B ;
ESSINK, M ;
HIDDEMANN, W .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (10) :2139-2146
[5]
CAFIERO F, 1992, SURGERY, V112, P24
[6]
COHEN J, 1985, LANCET, V2, P1069
[7]
Plasma antioxidant potential in severe sepsis: A comparison of survivors and nonsurvivors [J].
Cowley, HC ;
Bacon, PJ ;
Goode, HF ;
Webster, NR ;
Jones, JG ;
Menon, DK .
CRITICAL CARE MEDICINE, 1996, 24 (07) :1179-1183
[8]
ALPHA-TOCOPHEROL ATTENUATES LUNG EDEMA AND LIPID-PEROXIDATION CAUSED BY ACUTE ZYMOSAN-INDUCED PERITONITIS [J].
DEMLING, R ;
LALONDE, C ;
IKEGAMI, K ;
PICARD, L ;
NAYAK, U .
SURGERY, 1995, 117 (02) :226-231
[9]
DICHTELMULLER H, 1987, DRUG RES, V37, P1273
[10]
Antimicrobial treatment of intra-abdominal infections [J].
Elsakr, R ;
Johnson, DA ;
Younes, Z ;
Oldfield, EC .
DIGESTIVE DISEASES, 1998, 16 (01) :47-60